Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MXCT MaxCyte	$1.39 -0.7%	$1.94	$1.26 ▼ $5.20	$148.19M	1.23	794,813 shs	367,362 shs
NXTT Next Technology	$0.29 -51.7%	$1.99	$0.22 ▼ $4.80	$132.32M	7.46	3.30 million shs	67.22 million shs
PHLT Performant Healthcare	$7.60 +0.3%	$5.30	$2.17 ▼ $7.74	$600.40M	0.41	472,608 shs	679,888 shs
RPAY Repay	$5.94 +1.0%	$5.12	$3.59 ▼ $9.75	$542.56M	1.64	1.22 million shs	679,110 shs

Analysts Agree—These Gold Picks Outshine the Rest

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MXCT MaxCyte	+0.72%	+0.72%	-38.05%	-39.39%	-66.98%
NXTT Next Technology	-40.59%	-48.28%	-71.15%	-70.00%	-62.03%
PHLT Performant Healthcare	-0.26%	-0.52%	+107.67%	+165.03%	+757,999,900.00%
RPAY Repay	+0.86%	+6.33%	+10.11%	+22.50%	-30.08%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
MXCT MaxCyte	3.188 of 5 stars	3.3	2.0	3.0	3.3	1.3
NXTT Next Technology	1.3935 of 5 stars	0.0	3.0	4.0	1.7	0.6
PHLT Performant Healthcare	1.5931 of 5 stars	2.1	0.0	3.5	2.5	0.6
RPAY Repay	3.0247 of 5 stars	3.2	3.0	2.3	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MXCT MaxCyte	2.50	Moderate Buy	$7.00	401.79% Upside
NXTT Next Technology	0.00	N/A	N/A	N/A
PHLT Performant Healthcare	2.20	Hold	$7.88	3.48% Upside
RPAY Repay	2.44	Hold	$7.22	23.77% Upside

Current Analyst Ratings Breakdown

Latest MXCT, PHLT, RPAY, and NXTT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/22/2025	RPAY Repay	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00
8/13/2025	RPAY Repay	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$4.50 ➝ $5.75
8/13/2025	RPAY Repay	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$12.00 ➝ $10.00
8/12/2025	RPAY Repay	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Perform ➝ Market Perform	$5.00 ➝ $5.75
8/12/2025	RPAY Repay	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$4.50 ➝ $5.00
8/11/2025	MXCT MaxCyte	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral
8/7/2025	MXCT MaxCyte	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
8/4/2025	PHLT Performant Healthcare	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold	$7.75
8/4/2025	PHLT Performant Healthcare	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/4/2025	PHLT Performant Healthcare	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$7.75
8/1/2025	PHLT Performant Healthcare	Citizens Jmp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold

(Data available from 8/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MXCT MaxCyte	$38.63M	3.85	N/A	N/A	$1.79 per share	0.78
NXTT Next Technology	$1.80M	102.15	$1.22 per share	0.33	$1.18 per share	0.34
PHLT Performant Healthcare	$122.98M	4.89	N/A	N/A	$1.04 per share	7.32
RPAY Repay	$313.04M	1.70	$1.98 per share	2.94	$7.00 per share	0.83

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MXCT MaxCyte	-$41.06M	-$0.43	N/A	N/A	N/A	-125.22%	-22.12%	-19.10%	11/5/2025 (Estimated)
NXTT Next Technology	$21.55M	N/A	0.00	∞	N/A	N/A	45.56%	39.44%	11/13/2025 (Estimated)
PHLT Performant Healthcare	-$9.90M	-$0.01	N/A	N/A	N/A	-0.64%	-0.04%	-0.03%	11/5/2025 (Estimated)
RPAY Repay	-$10.16M	-$1.26	N/A	7.58	N/A	-35.79%	8.89%	4.31%	11/11/2025 (Estimated)

Latest MXCT, PHLT, RPAY, and NXTT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/11/2025	Q2 2025	RPAY Repay	$0.20	$0.20	N/A	-$1.15	$74.24 million	$75.63 million
8/8/2025	Q2 2025	NXTT Next Technology	N/A	$0.27	N/A	$0.27	N/A	N/A
8/6/2025	Q2 2025	MXCT MaxCyte	-$0.10	-$0.12	-$0.02	-$0.12	$9.57 million	$8.51 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
MXCT MaxCyte	N/A	N/A	N/A	N/A	N/A
NXTT Next Technology	N/A	N/A	N/A	N/A	N/A
PHLT Performant Healthcare	N/A	N/A	N/A	N/A	N/A
RPAY Repay	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MXCT MaxCyte	N/A	12.40	11.71
NXTT Next Technology	N/A	253.31	253.31
PHLT Performant Healthcare	0.10	2.64	2.64
RPAY Repay	0.44	0.85	0.85

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MXCT MaxCyte	68.81%
NXTT Next Technology	2.71%
PHLT Performant Healthcare	77.15%
RPAY Repay	82.73%

Insider Ownership

Company	Insider Ownership
MXCT MaxCyte	3.30%
NXTT Next Technology	37.50%
PHLT Performant Healthcare	9.10%
RPAY Repay	12.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MXCT MaxCyte	80	106.61 million	103.09 million	Optionable
NXTT Next Technology	8	456.27 million	285.17 million	N/A
PHLT Performant Healthcare	930	79.00 million	71.81 million	N/A
RPAY Repay	580	91.34 million	80.38 million	Optionable

MXCT, PHLT, RPAY, and NXTT Headlines

Recent News About These Companies

Nuveen LLC Buys Shares of 1,034,820 Repay Holdings Corporation $RPAY

August 28 at 3:36 AM | marketbeat.com

Repay (NASDAQ:RPAY) Earns "Buy" Rating from Canaccord Genuity Group

August 27 at 8:26 AM | marketbeat.com

Wellington Management Group LLP Increases Stock Position in Repay Holdings Corporation $RPAY

August 27 at 4:11 AM | marketbeat.com

Why Repay Holdings (RPAY) Might be Well Poised for a Surge

August 26 at 1:21 PM | zacks.com

Sunriver Management LLC Buys 125,133 Shares of Repay Holdings Corporation $RPAY

August 26 at 8:10 AM | marketbeat.com

American Century Companies Inc. Raises Holdings in Repay Holdings Corporation $RPAY

August 25 at 3:55 AM | marketbeat.com

Brokerages Set Repay Holdings Corporation (NASDAQ:RPAY) Target Price at $7.22

August 25 at 3:07 AM | americanbankingnews.com

Repay Holdings Corporation (NASDAQ:RPAY) Given Consensus Recommendation of "Hold" by Brokerages

August 24, 2025 | marketbeat.com

Russell Investments Group Ltd. Has $6.87 Million Stock Holdings in Repay Holdings Corporation $RPAY

August 23, 2025 | marketbeat.com

Repay (NASDAQ:RPAY) & Mercurity Fintech (NASDAQ:MFH) Head to Head Review

August 23, 2025 | americanbankingnews.com

Repay (NASDAQ:RPAY) Upgraded to "Buy" at Wall Street Zen

August 19, 2025 | americanbankingnews.com

Deutsche Bank AG Sells 103,943 Shares of Repay Holdings Corporation (NASDAQ:RPAY)

August 18, 2025 | marketbeat.com

Repay (NASDAQ:RPAY) Stock Rating Upgraded by Wall Street Zen

August 17, 2025 | marketbeat.com

Repay (NASDAQ:RPAY) Price Target Raised to $5.75

August 15, 2025 | marketbeat.com

DA Davidson Has Lowered Expectations for Repay (NASDAQ:RPAY) Stock Price

August 15, 2025 | marketbeat.com

UBS Sticks to Their Hold Rating for Repay Holdings (RPAY)

August 15, 2025 | theglobeandmail.com

Repay Holdings price target raised to $5.75 from $4.50 at UBS

August 13, 2025 | msn.com

Repay Holdings Corporation (NASDAQ:RPAY) Q2 2025 Earnings Call Transcript

August 13, 2025 | msn.com

Repay (NASDAQ:RPAY) Given New $5.75 Price Target at Keefe, Bruyette & Woods

August 13, 2025 | marketbeat.com

Repay (NASDAQ:RPAY) Shares Gap Up on Analyst Upgrade

August 13, 2025 | marketbeat.com

Repay (NASDAQ:RPAY) Price Target Raised to $5.00

August 13, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MXCT, PHLT, RPAY, and NXTT Company Descriptions

MaxCyte NASDAQ:MXCT

$1.39 -0.01 (-0.71%)

Closing price 04:00 PM Eastern

Extended Trading

$1.40 +0.01 (+0.72%)

As of 05:27 PM Eastern

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Next Technology NASDAQ:NXTT

$0.29 -0.31 (-51.75%)

Closing price 04:00 PM Eastern

Extended Trading

$0.31 +0.02 (+6.90%)

As of 05:47 PM Eastern

Next Technology Holding Inc. provides technical services and solutions through its social e-commerce platform primarily in Mainland China. It offers YCloud, a micro-business cloud intelligent internationalization system that conducts multi-channel data analysis through the learning of big data and social recommendation relationships, as well as provides users with AI fission and management systems, and supply chain systems. The company's YCloud system also provides micro-business owners with various payment methods, such as Alipay, WeChat, and UnionPay. In addition, it offers chatGPT technical services; and technical system support, software development, and services. The company serves individual and corporate users in the micro business industry. It also has operations in Hong Kong and Singapore. The company was formerly known as WeTrade Group, Inc. and changed its name to Next Technology Holding Inc in April 2024. Next Technology Holding Inc. was incorporated in 2019 and is headquartered in Beijing, the People Republic of China.

Performant Healthcare NASDAQ:PHLT

$7.60 +0.02 (+0.26%)

As of 04:00 PM Eastern

Performant Healthcare, Inc. engages in the provision of technology-enabled audit, recovery, customer care, and related analytics services. Its services help identify improper payments, and in some markets, restructure and recover delinquent or defaulted assets and improper payments for both government and private clients. The company was founded in 1976 and is headquartered in Plantation, FL.

Repay NASDAQ:RPAY

$5.94 +0.06 (+1.02%)

Closing price 04:00 PM Eastern

Extended Trading

$5.94 +0.00 (+0.08%)

As of 05:08 PM Eastern

Repay Holdings Corporation, payments technology company, provides integrated payment processing solutions to industry-oriented markets in the United States. It operates through two segments: Consumer Payments and Business Payments. The company's payment processing solutions enable consumers and businesses to make payments using electronic payment methods. It also offers a range of solutions relating to electronic payment methods, including credit and debit card processing, automated clearing house (ACH) processing, e-cash, and digital wallet services; virtual credit card processing, enhanced ACH processing, instant funding, clearing and settlement, and communication solutions; and proprietary payment channels that include Web-based, virtual terminal, online client portal, mobile application, text-to-pay, interactive voice response, and point of sale services. It serves customers primarily operating in the personal loans, automotive loans, receivables management, and business-to-business verticals through direct sales representatives and software integration partners. The company was founded in 2006 and is headquartered in Atlanta, Georgia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time